22-26 September | International Congress of Parkinson’s Disease & Movement Disorders

Event name: International Congress of Parkinson’s Disease & Movement Disorders

Date: 22-26 September 2019

Venue: Nice, France

ERN-RND members participating in the Congress:

  • Wassilios Meissner, France (CSPC Liaison, Session: “Diagnosis and Treatment of Atypical Parkinsonian Disorders“, 22.09 / CSPC Liaison, Teaching Course: “Integrated Management of Movement Disorders: The Example of Parkinson’s Disease“, 23.09 / Chair and Speaker, Session: “Drug Repurposing in Parkinson’s Disease“, 24.09 / CSPC Liaison, Teaching Course: “Pediatric Movement Disorders” & “Recognition & Management of Sleep Disturbances in Movement Disorders on 24.09, “Recognition of and Management of Non-Motor Symptoms in Parkinson’s Disease” &Palliative Care in Parkinson’s Disease” on 25.09)
  • Marie Vidailhet, France (Speaker, Session: “Therapeutic Options for Dystonia“, 22.09 / Chair, Session: “Translational Science of Dystonia“, 24.09)
  • Christine Klein, Germany (Speaker, Session: “C. David Marsden Lecture: Reduced Penetrance of Hereditary Movement Disorders: Elucidating Mechanisms of Endogenous Disease Protection“, 23.09)
  • Alexandra Durr, France (Speaker and Chair, Ataxia Session: “From Phenotype to Genotype in Ataxia“, 23.09)
  • Lugder Schöls, Germany (Speaker, Ataxia Session: “Ataxia Syndromes in Adults and Children“, 23.09)
  • Huw Morris, UK (Speaker, Parkinson’s Disease and Atypical Parkinsonism: Tauopathies vs. Synucleinopathies Session: “Disease Modifying Therapies“, 23.09)
  • Matthis Synofzik, Germany (Skills Worshop,  “Using Genetic Tools for Diagnosis“, 23.09)
  • Kailash Bhatia, UK (Chair, Plenary Session: “Tremor Disorders: Challenges and Future Directions”, 24.09)
  • Marina De Koning-Thijssen, the Netherlands (Chair, Session: “Myoclonus“, 24.09)
  • Sarah Tabrizi, UK (Speaker, Huntington’s Disease: from Bench to Bedside Session: “Current and Future Therapies for Huntington’s Disease“, 25.09)
  • Evžen Růžička, Czech Republic (Skills Workshop: “Practical Use of the MDS-UPDRS“, 25.09)
  • Thomas Klopstock, Germany (Speaker, Science of Industry Session-non CME: “PKAN: A Comparison of Multiple Potential Mechanisms and Treatment Strategies for Addressing the Biochemical Defect“, 23.09)
  • Massimo Pandolfo, Belgium (Speaker, Speaker, Science of Industry Session-non CME: “Reducing Brain Iron in Degenerative Disorders“, 23.09)

Please check the MDS programme for more information as some of our ERN-RND members mentioned above will be participating in sessions in a variety of formats, not mentioned here.

Information about the congress can be found on the International Parkinson and Movement Disorder Society webpage here.